211 related articles for article (PubMed ID: 12792856)
1. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
Czura CJ; Yang H; Tracey KJ
J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
Lutz W; Stetkiewicz J
Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
[TBL] [Abstract][Full Text] [Related]
3. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 as a DNA-binding cytokine.
Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 as a cytokine and therapeutic target.
Yang H; Wang H; Czura CJ; Tracey KJ
J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
[TBL] [Abstract][Full Text] [Related]
6. The gesture life of high mobility group box 1.
Friedman SG; Czura CJ; Tracey KJ
Curr Opin Clin Nutr Metab Care; 2003 May; 6(3):283-7. PubMed ID: 12690260
[TBL] [Abstract][Full Text] [Related]
7. The role of high mobility group box-1 protein in severe sepsis.
Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ
Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483
[TBL] [Abstract][Full Text] [Related]
8. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1.
Mullins GE; Sunden-Cullberg J; Johansson AS; Rouhiainen A; Erlandsson-Harris H; Yang H; Tracey KJ; Rauvala H; Palmblad J; Andersson J; Treutiger CJ
Scand J Immunol; 2004 Dec; 60(6):566-73. PubMed ID: 15584967
[TBL] [Abstract][Full Text] [Related]
9. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
Erlandsson Harris H; Andersson U
Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
[TBL] [Abstract][Full Text] [Related]
10. The cytokine activity of HMGB1.
Yang H; Wang H; Czura CJ; Tracey KJ
J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
[TBL] [Abstract][Full Text] [Related]
11. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.
Kim JH; Kim SJ; Lee IS; Lee MS; Uematsu S; Akira S; Oh KI
J Immunol; 2009 Feb; 182(4):2458-66. PubMed ID: 19201901
[TBL] [Abstract][Full Text] [Related]
12. Endogenous HMGB1 is required in endotoxin tolerance.
Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 (HMGB1) protein: friend and foe.
Ulloa L; Messmer D
Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
[TBL] [Abstract][Full Text] [Related]
14. [Effects of escharectomy during shock stage on tissue high mobility group box-1 expression and balance of pro-/anti-inflammatory response in rats after severe thermal injury].
Wang ZT; Yao YM; Sheng ZY; Yu Y; Yang HM; Wang Q; Liu Q; Qiao L; Zhou G
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(14):839-44. PubMed ID: 15363270
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.
Huston JM; Gallowitsch-Puerta M; Ochani M; Ochani K; Yuan R; Rosas-Ballina M; Ashok M; Goldstein RS; Chavan S; Pavlov VA; Metz CN; Yang H; Czura CJ; Wang H; Tracey KJ
Crit Care Med; 2007 Dec; 35(12):2762-8. PubMed ID: 17901837
[TBL] [Abstract][Full Text] [Related]
16. HMGB1, a potent proinflammatory cytokine in sepsis.
Huang W; Tang Y; Li L
Cytokine; 2010 Aug; 51(2):119-26. PubMed ID: 20347329
[TBL] [Abstract][Full Text] [Related]
17. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
[TBL] [Abstract][Full Text] [Related]
18. Systemic and local high mobility group box 1 concentrations during severe infection.
van Zoelen MA; Laterre PF; van Veen SQ; van Till JW; Wittebole X; Bresser P; Tanck MW; Dugernier T; Ishizaka A; Boermeester MA; van der Poll T
Crit Care Med; 2007 Dec; 35(12):2799-804. PubMed ID: 17901841
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
Andersson U; Tracey KJ
Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
[TBL] [Abstract][Full Text] [Related]
20. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
